April 2004
Gut;Apr2004 Supplement 3, Vol. 53, pA79
Academic Journal
Self expanding metal stents (SEMS) have been successfully used in the management of oesophageal cancers. However there have been few data that have demonstrated successful deployment of gastric stents for palliation of gastric cancers. The aim of this study was to assess the safety, efficacy and success of SEMS in the management of inoperable stomach cancer. Researchers have shown successful palliation with SEMS. None of the patients in this study required any surgery and no complications were seen.


Related Articles

  • Surgical issues after neoadjuvant treatment for gastric cancer. D'UGO, D.; PERSIANI, R.; ZOCCALI, M.; CANANZI, F.; VIGORITA, V.; MAZZEO, P.; TUFO, A.; BIONDI, A. // European Review for Medical & Pharmacological Sciences;2010, Vol. 14 Issue 4, p315 

    Gastric carcinoma is one of the most frequent malignancies in the world and its clinical behavior depends on the metastatic potential of the tumour. Particularly, lymphatic metastasis is one of the main predictor of tumour recurrence and survival and current pathologic staging systems reflect...

  • Esophageal cancer: self-expanding metallic stents. Sabharwal, T.; Morales, J.; Salter, R.; Adam, A. // Abdominal Imaging;Jul/Aug2005, Vol. 30 Issue 4, p456 

    Discusses the use of esophageal stents to achieve the most rapid relief of symptoms and recanalize malignant obstructions of the esophagus in cases of esophageal cancer. Other non-surgical palliative techniques for recanalizing malignant obstruction; Other therapeutic modalities; Implications on...

  • Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report†. Okines, A. F. C.; Langley, R. E.; Thompson, L. C.; Stenning, S. P.; Stevenson, L.; Falk, S.; Seymour, M.; Coxon, F.; Middleton, G. W.; Smith, D.; Evans, L.; Slater, S.; Waters, J.; Ford, D.; Hall, M.; Iveson, T. J.; Petty, R. D.; Plummer, C.; Allum, W. H.; Blazeby, J. M. // Annals of Oncology;Mar2013, Vol. 24 Issue 3, p702 

    Background Peri-operative chemotherapy and surgery is a standard treatment of localised oesophagogastric adenocarcinoma; however, the outcomes remain poor. Patients and methods ST03 is a multicentre, randomised, phase II/III study comparing peri-operative ECX with or without bevacizumab (ECX-B)....

  • OPERABILITY AND CURATIVE RESECTION RATE IN GASRTIC CARCINOMA: AN EXPERIENCE AT PESHAWAR, PAKISTAN. Shah, Rahmat Ullah; Khan, Faiz Muhammad; Javed, Muhammad; Tayyeb, Muhammad; Babar, Tariq Sohail // Gomal Journal of Medical Sciences;Apr-Jun2014, Vol. 12 Issue 2, p72 

    Background: Gastric carcinoma is the second leading cause of cancer related deaths in the world and the fourth most commonly diagnosed cancer worldwide. Curative therapy for gastric cancer involves surgical resection i.e. total or subtotal gastrectomy with an accompanying lymphadenectomy. The...

  • Short-term outcome of total laparoscopic distal gastrectomy for overweight and obese patients with gastric cancer. Sugimoto, Motokazu; Kinoshita, Takahiro; Shibasaki, Hidehito; Kato, Yuichiro; Gotohda, Naoto; Takahashi, Shinichiro; Konishi, Masaru // Surgical Endoscopy;Nov2013, Vol. 27 Issue 11, p4291 

    Background: Laparoscopic distal gastrectomy for gastric cancer has been firmly established in recent decades but still is a difficult procedure, especially for obese patients, as with open surgery. This study aimed to evaluate the perioperative outcome of total laparoscopic distal gastrectomy...

  • New Design Esophageal Stents for the Palliation of Dysphagia From Esophageal or Gastric Cardia Cancer: A Randomized Trial. Verschuur, Els M. L.; Repici, Alessandro; Kuipers, Ernst J.; Steyerberg, Ewout W.; Siersema, Peter D. // American Journal of Gastroenterology;Feb2008, Vol. 103 Issue 2, p304 

    BACKGROUND & AIM: Stents are often used for the palliation of inoperable esophageal or gastric cardia cancer. One of the drawbacks of the currently used stents is the high percentage of recurrent dysphagia due to stent migration and tissue growth. New stents have been designed to overcome this...

  • Does adding ICU data to the POSSUM score improve the prediction of outcomes following surgery for upper gastrointestinal malignancies? Butterfield, R.; Stedman, W.; Herod, R.; Aneman, A. // Anaesthesia & Intensive Care;2015, Vol. 43 Issue 4, p490 

    Surgery for upper gastrointestinal malignancy carries a high postoperative mortality and morbidity risk. The importance of preoperative physiological reserve and intraoperative events in determining clinical outcomes is recognised in the Physiological and Operative Severity Score for the...

  • Ultrasound-guided transversus abdominis plane block for control of postoperative pain after laparoscopy-assisted robotic abdominal cancer surgery. Mahran, Essam; Hassan, Mohamed E. // Ain Shams Journal of Anesthesiology;Oct-Dec2016, Vol. 9 Issue 4, p558 

    Background and objective Transversus abdominis plane (TAP) block is a recently developed method for analgesia that is now widely used in a variety of abdominal surgeries. Robotic laparoscopy is being increasingly adopted for surgical resection of abdominal cancers. We studied the efficacy and...

  • Current status of laparoscopic gastrectomy for cancer in Japan. Kitano, S.; Shiraishi, N. // Surgical Endoscopy;Feb2004, Vol. 18 Issue 2, p182 

    Because of the increased incidence of early gastric cancer in Japan, minimally invasive laparoscopic approaches to gastric malignancies have been under development since 1991. Laparoscopic local resection of the stomach, i.e., laparoscopic wedge resection (LWR) and intragastric mucosal resection...


Read the Article


Sign out of this library

Other Topics